Status:

COMPLETED

Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone

Lead Sponsor:

Merck KGaA, Darmstadt, Germany

Collaborating Sponsors:

Merck, S.L., Spain

Conditions:

Infant, Small for Gestational Age

Eligibility:

All Genders

Brief Summary

This non-interventional study for prospective follow up of a cohort of 220 subjects born small for gestational age (SGA) is planned for the purpose of finding out if normalisation of adult height is a...

Detailed Description

The small for gestational age (SGA) concept includes babies born to term whose weight and/or height is lower than two standard deviations (SD) below the mean. Pathologically short stature is understoo...

Eligibility Criteria

Inclusion

  • Children with growth disorder (current height \<-2.5 SD and height adjusted to parental stature \<-1 SD) in children born SGA with a weight and/or length at birth below -2 SD, that has not experimented a growth catch-up (growth speed \<0 SD during the last year) at 4 years old or afterwards were enrolled in the study
  • Children undergoing treatment with somatropin from Serono
  • Children whose parent or legal guardians, as well as the subject himself if 12 or more years old have given written permission to access their records

Exclusion

  • Children with closed epiphysis
  • Children with known hypersensitivity to somatropin or to any excipients present in the injection powder or solvent
  • Subjects with active neoplasms. Any anti-tumoral treatment must be completed prior to starting treatment with somatropin
  • Subjects with evidence of progression or relapse of a subjacent intracranial lesion
  • Subjects with acute critical diseases such as those that present complications after open heart surgery, abdominal surgery, polytraumatisms, acute respiratory failure or similar conditions

Key Trial Info

Start Date :

September 30 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2018

Estimated Enrollment :

443 Patients enrolled

Trial Details

Trial ID

NCT01196156

Start Date

September 30 2005

End Date

December 31 2018

Last Update

February 27 2019

Active Locations (28)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (28 locations)

1

Hospital Universitario Príncipe de Asturias

Alcalá de Henares, Madrid, Spain

2

Hospital General de Alicante

Alicante, Spain

3

Hospital Nostra Senyora de Meritxell

Andorra, Spain

4

Hospital San Agustin

Avilés, Spain